Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday

Comments
Loading...

U.S. stocks were lower, with the Dow Jones index falling over 100 points on Wednesday.

Shares of Cognyte Software Ltd. CGNT rose sharply during Wednesday's session after the company reported better-than-expected fourth-quarter financial results.

Cognyte Software posted adjusted earnings of 3 cents per share, beating market estimates of 1 cent per share. The company's quarterly sales came in at $94.505 million versus expectations of $93.154 million.

Cognyte Software shares jumped 22.1% to $10.04 on Wednesday.

Here are some other big stocks recording gains in today's session.

  • AngioDynamics, Inc. ANGO shares rose 13.7% to $10.98 after the company reported better-than-expected third-quarter sales results and raised its FY25 guidance above estimates.
  • Rocket Companies, Inc. RKT gained 13.1% to $14.26.
  • Cytokinetics, Incorporated CYTK shares rose 12% to $41.99.
  • Redfin Corporation RDFN shares surged 11.7% to $10.69.
  • CoreWeave, Inc. CRWV gained 10.1% to $57.90.
  • Gyre Therapeutics, Inc. GYRE rose 9.8% to $7.04.
  • Mr. Cooper Group Inc. COOP surged 9.5% to $136.97.
  • Sana Biotechnology, Inc. SANA gained 8.3% to $1.6250.
  • Allegiant Travel Company ALGT rose 7.1% to $54.45. Raymond James analyst Savanthi Syth upgraded Allegiant Travel from Outperform to Strong Buy and lowered the price target from $125 to $90.
  • Studio City International Holdings Limited MSC gained 7% to $3.85.
  • Arcellx, Inc. ACLX gained 5.9% to $64.28.
  • Ciena Corporation CIEN shares rose 4.6% to $64.34.
  • RH RH rose 3.8% to $248.24 ahead of quarterly earnings.

Now Read This:

Photo via Shutterstock

Got Questions? Ask
Which tech stocks could follow Cognyte's lead?
How will AngioDynamics impact healthcare investments?
Are there real estate stocks to watch after Redfin's surge?
What does Rocket Companies' gain mean for housing market trends?
How might biotech firms benefit from Cytokinetics' results?
Could travel stocks see a boost after Allegiant's upgrade?
Which ETFs could capitalize on recent stock movements?
How will market sentiment shift after these earnings reports?
What investments could gain from Cognyte's growth in cybersecurity?
Which companies could be affected by analyst upgrades like Allegiant's?
Market News and Data brought to you by Benzinga APIs

Posted In: